化疗与内分泌治疗相结合:新瓶中的旧葡萄酒?
Nengying Zhang1, Liyi Pan2, Tao Weng2
1Department of General Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, China; Division of Breast and Thyroid Surgery, Department of General Surgery, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Clinical breast cancer
|September 17, 2024
概括
同时的化疗和内分泌疗法对乳腺癌可能比连续治疗更有效. 最近的研究表明协同作用,挑战以前的发现和当前对激素受体阳性乳腺癌的指导方针.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 化疗 (CT) 和内分泌疗法 (ET) 是乳腺癌 (BC) 的关键治疗方法.
- 从历史上看,同时CT和ET表现出对抗性作用,有利于对激素受体阳性 (HR+) BC的顺序给予.
- 目前的指导方针建议 HR+BC 进行顺序CT和ET.
研究的目的:
- 审查乳腺癌化学疗法和内分泌疗法联合治疗的最新进展.
- 为了解决由于新的内分泌药物而对同时CT和ET的重新临床兴趣.
- 评估结合某些化疗剂与内分泌药物的潜在协同效应.
主要方法:
- 关于CT和ET在乳腺癌治疗中的最新研究的文献综述.
- 对临床数据和研究结果的分析,涉及同步与顺序给予.
- 综合关于特定化疗剂和内分泌药物之间的协同作用的证据.
主要成果:
- 最近的研究表明,某些化疗剂和内分泌药物之间可能存在协同作用.
- 同时CT和ET的疗效正在根据新的治疗选择进行重新评估.
- 有证据表明,结合CT和ET可能在特定情况下比顺序管理提供优势.
结论:
- 乳腺癌化疗和内分泌治疗的最佳安排是一个不断发展的领域.
- 较新的内分泌药物可能会改变对CT和ET同时使用的传统观点.
- 需要进一步的研究来澄清CT和ET联合治疗乳腺癌患者的益处和风险.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
236
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
236


